4.8 Article

COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis

期刊

NATURE GENETICS
卷 47, 期 6, 页码 654-660

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ng.3279

关键词

-

资金

  1. US National Institutes of Health (NIH) grant [R01AI067946]
  2. Jeffrey Modell Foundation
  3. US NIH grant [K08HL095659, K23NS078056, AI053831]
  4. Foundation of the American Thoracic Society
  5. Pulmonary Fibrosis Foundation
  6. Nina Ireland Lung Disease Program
  7. US NIH (National Human Genome Research Institute/National Heart, Lung, and Blood Institute) grant [U54HG006542]
  8. (National Institute of Neurological Disorders and Stroke) grant [2RO1NS058529]
  9. US NIH (National Human Genome Research Institute) grant [U54HG003273]

向作者/读者索取更多资源

Unbiased genetic studies have uncovered surprising molecular mechanisms in human cellular immunity and autoimmunity(1). We performed whole-exome sequencing and targeted sequencing in five families with an apparent mendelian syndrome of autoimmunity characterized by high-titer autoantibodies, inflammatory arthritis and interstitial lung disease. We identified four unique deleterious variants in the COPA gene (encoding coatomer subunit alpha) affecting the same functional domain. Hypothesizing that mutant COPA leads to defective intracellular transport via coat protein complex I (COPI)(2-4), we show that COPA variants impair binding to proteins targeted for retrograde Golgi-to-ER transport. Additionally, expression of mutant COPA results in ER stress and the upregulation of cytokines priming for a T helper type 17 (T(H)17) response. Patient-derived CD4(+)T cells also demonstrate significant skewing toward a T(H)17 phenotype that is implicated in autoimmunity(5,6). Our findings uncover an unexpected molecular link between a vesicular transport protein and a syndrome of autoimmunity manifested by lung and joint disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据